trending Market Intelligence /marketintelligence/en/news-insights/trending/j24iNT87bVCmB4h-IIpeEg2 content esgSubNav
In This List

Genus wins legal case against animal genetics company

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Genus wins legal case against animal genetics company

Genus PLC said the U.S. District Court for the Western District of Wisconsin issued a permanent injunction against Inguran LLC, operating as Sexing Technologies, in connection with a 2012 semen sorting agreement between Inguran and Genus' ABS Global Inc. unit.

The permanent injunction prohibits Inguran from invoking certain research, marketing and noncompete restrictions stated in the agreement. In addition, other bull studs in the U.S are now allowed to terminate their Inguran sexed semen processing agreements on 12 months' notice, without damage or penalty. Inguran is required to provide written notice to other bull studs of the court's decision.

The injunction is effective for five years while the 2012 agreement will expire Aug. 31. Genus is also considering appeal options in relation to other post-verdict motion decisions from the court, including its decision to support the validity of certain Inguran patents.

Genus said it will launch Genus Sexed Semen technology in the U.S. and other key global markets in 2017, since the court has removed contractual restrictions blocking its commercial launch.